๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

301 Glycogen synthase kinase-3 and the phosphorylation of tau and APP

โœ Scribed by B.H. Anderton; A.E. Aplin; P.M. Bayley; J.-P. Brion; D.R. Davis; J.-M. Gallo; G.M. Gibb; D.P. Hanger; J.S. Jacobson; S. Lovestone; C.H. Reynolds; M. Utton; A. Vandecandelaere


Book ID
117413930
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
153 KB
Volume
17
Category
Article
ISSN
0197-4580

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Inhibition of proteasome and Shaggy/Glyc
โœ Olivier Blard; Thierry Frรฉbourg; Dominique Campion; Magalie Lecourtois ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 676 KB

## Abstract Tauopathies, including Alzheimer's disease (AD), are a group of neurodegenerative disorders characterized by the presence of intraneuronal filamentous inclusions of abnormally phosphorylated tau protein. In AD brains, it has been shown that the level of abnormally phosphorylated tau is